The WACC of PHI Group Inc (PHIL) is 4.9%.
Range | Selected | |
Cost of equity | 5.3% - 6.8% | 6.05% |
Tax rate | 26.2% - 27.0% | 26.6% |
Cost of debt | 5.0% - 5.0% | 5% |
WACC | 4.5% - 5.3% | 4.9% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.31 | 0.34 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 5.3% | 6.8% |
Tax rate | 26.2% | 27.0% |
Debt/Equity ratio | 0.95 | 0.95 |
Cost of debt | 5.0% | 5.0% |
After-tax WACC | 4.5% | 5.3% |
Selected WACC | 4.9% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
PHIL | PHI Group Inc | 0.95 | -0.77 | -0.45 |
ADTX | ADiTx Therapeutics Inc | 2.28 | 0.53 | 0.2 |
CBCA | Crown Baus Capital Corp | 1367.59 | -0.32 | 0 |
CNNE | Cannae Holdings Inc | 0.13 | 0.9 | 0.82 |
CUEN | Cuentas Inc | 465.2 | 0.94 | 0 |
NGEN.V | NervGen Pharma Corp | 0 | -0.28 | -0.28 |
RAFI | Regency Affiliates Inc | 1.86 | -0.11 | -0.05 |
SEMUF | Siem Industries Inc | 1 | 0.07 | 0.04 |
THRM.V | Therma Bright Inc | 0.01 | 0.3 | 0.3 |
XAU.TO | GoldMoney Inc | 0.33 | -0.22 | -0.18 |
Low | High | |
Unlevered beta | -0.02 | 0.02 |
Relevered beta | -0.03 | 0.01 |
Adjusted relevered beta | 0.31 | 0.34 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for PHIL:
cost_of_equity (6.05%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.31) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.